Revision history of "Studies of tumor heterogeneity using dedicated PET breast with proliferation tracers: early detection of response to treatment" (Q3141142)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 20:0820:08, 17 August 2022DG Regio talk contribs 77,890 bytes +53,746 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 12:3212:32, 2 December 2021DG Regio talk contribs 15,815 bytes +2,716 Created claim: summary (P836): Le cancer du sein est l’une des tumeurs les plus courantes chez les femmes occidentales. Bien que beaucoup de progrès aient été réalisés dans les traitements de cette pathologie, nous ne savons toujours pas comment évaluer avec précision et tôt la réponse au traitement néoadjuvant. Il en résulte un nombre important de patients traités inutilement, avec des dommages correspondants pour les patients et le coût des ressources hospitalières. Dans ce...
  • curprev 12:3212:32, 2 December 2021DG Regio talk contribs 13,099 bytes +222 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 13:2613:26, 12 October 2021DG Regio talk contribs 12,877 bytes +186 Changed label, description and/or aliases in en: translated_label
  • curprev 13:2613:26, 12 October 2021DG Regio talk contribs 12,691 bytes +2,371 Created claim: summary (P836): Breast cancer is one of the most common tumors among Western women. Although much progress has been made in the treatments of this pathology, we still do not know how to accurately and early evaluate the response to neoadjuvant treatment. This results in a significant number of patients treated unnecessarily, with corresponding harm to patients and expense of hospital resources. In this context, positron emission tomography (PET) is a valuable t...

10 October 2021

9 October 2021

7 October 2021